Primers were designed to amplify the coding exons of
ADAR1 (
Supplementary Table S1, online-only). Purified polymerase chain
reaction (PCR) amplification products were sequenced using BigDye terminator
chemistry and an ABI
3130 DNA sequencer. Mutation description is based on the
reference cDNA sequence NM_001111.4, with nucleotide numbering beginning from
the first A in the initiating ATG codon. Variants were assessed using the in
silico programs SIFT (
http://sift.jcvi.org) and
Polyphen2 (
http://genetics.bwh.harvard.edu/pph2/), and population allele
frequencies obtained from the ExAC (
http://exac.broadinstitute.org) and gnomAD (
http://gnomad.broadinstitute.org) databases.
Rice G.I., Kitabayashi N., Barth M., Briggs T.A., Burton A.C., Carpanelli M.L., Cerisola A.M., Colson C., Dale R.C., Danti F.R., Darin N., De Azua B., De Giorgis V., De Goede C.G., Desguerre I., De Laet C., Eslahi A., Fahey M.C., Fallon P., Fay A., Fazzi E., Gorman M.P., Gowrinathan N.R., Hully M., Kurian M.A., Leboucq N., Lin J.P., Lines M.A., Mar S.S., Maroofian R., Martí-Sanchez L., McCullagh G., Mojarrad M., Narayanan V., Orcesi S., Ortigoza-Escobar J.D., Pérez-Dueñas B., Petit F., Ramsey K.M., Rasmussen M., Rivier F., Rodríguez-Pombo P., Roubertie A., Stödberg T.I., Toosi M.B., Toutain A., Uettwiller F., Ulrick N., Vanderver A., Waldman A., Livingston J.H, & Crow Y.J. (2017). Genetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease. Neuropediatrics, 48(3), 166-184.